Eribulin monotherapy in patients aged 70 years and older with metastatic breast cancer. - Wikidata - wikimedia - TriplyDB

Eribulin monotherapy in patients aged 70 years and older with metastatic breast cancer.

Eribulin monotherapy in patients aged 70 years and older with metastatic breast cancer.

http://www.wikidata.org/entity/Q37698199

about

Eribulin in the Management of Advanced Breast Cancer: Implications of Current Research Findings Eribulin in Cancer Treatment Optimal management of breast cancer in the elderly patient: current perspectives Eribulin for the treatment of metastatic breast cancer: an update on its safety and efficacy Efficacy of eribulin in breast cancer: a short report on the emerging new data.Eribulin for heavily pre-treated metastatic breast cancer patients Eribulin in pretreated metastatic breast cancer patients: results of the TROTTER trial-a multicenter retrospective study of eribulin in real life.Eribulin mesylate in advanced breast cancer: retrospective review of a single institute experience.Review on the clinical use of eribulin mesylate for the treatment of breast cancer.Comparative "nocebo effects" in older patients enrolled in cancer therapeutic trials: Observations from a 446-patient cohort.Eribulin in advanced breast cancer: safety, efficacy and new perspectives.Time-to-Treatment-Failure and Related Outcomes Among 1000+ Advanced Non-Small Cell Lung Cancer Patients: Comparisons Between Older Versus Younger Patients (Alliance A151711).

P2860

Q26774097-AA990A4E-96EF-4753-A286-37547F6317D4 Q26799328-6DED68D1-1BD1-4CE9-80C7-91E842257EEC Q27690879-A9FD703B-2047-4A83-8818-B359693BB627 Q28088354-A80BBD2E-2032-4B16-BFCE-0C042C94617D Q31167441-CF02F6AE-8528-4723-94E0-7C6E2BA645C6 Q35756426-B9D6DE72-0BCA-4AFA-B85F-AD5CC18A8021 Q36484243-53D5F0DC-EB20-4A1B-AC45-E79781AB47C0 Q38559355-16FD88F7-688A-46D8-BA3D-E8F78AAB7603 Q38711371-D80D2913-2386-47FF-94FC-5A4336956FAE Q46984149-B209B26C-4462-4486-9E60-A1DE560A9131 Q47794057-A73DEB20-FCB8-45F7-BDDB-8F3625F98EFF Q52612984-5D70C6A5-9849-4D7E-90C6-A50C10C44B2A

P2860

Eribulin monotherapy in patients aged 70 years and older with metastatic breast cancer.

http://www.wikidata.org/entity/Q37698199

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 28 March 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Eribulin monotherapy in patients aged 70 years and older with metastatic breast cancer.

@en

Eribulin monotherapy in patients aged 70 years and older with metastatic breast cancer.

@en-gb

Eribulin monotherapy in patients aged 70 years and older with metastatic breast cancer.

@nl

type

label

Eribulin monotherapy in patients aged 70 years and older with metastatic breast cancer.

@en

Eribulin monotherapy in patients aged 70 years and older with metastatic breast cancer.

@en-gb

Eribulin monotherapy in patients aged 70 years and older with metastatic breast cancer.

@nl

prefLabel

Eribulin monotherapy in patients aged 70 years and older with metastatic breast cancer.

@en

Eribulin monotherapy in patients aged 70 years and older with metastatic breast cancer.

@en-gb

Eribulin monotherapy in patients aged 70 years and older with metastatic breast cancer.

@nl

P1433

Q37698199-CF77C9AB-47F2-4062-A4A0-8CB52B463289

P1476

Q37698199-EFE2771C-9604-445E-94A6-338C91E54BC2

P2093

Q37698199-05694298-3213-4B71-9154-E65D1FBE77BB

Q37698199-647201FA-902B-4A6B-8E9D-B86D2464F80F

Q37698199-7C8FADC0-32C0-4DFE-9052-BDB82C8C36C1

Q37698199-861143C6-6CD7-41E8-AC79-B85B39AB4A8A

Q37698199-8E0D13D9-E7E8-4D84-825F-94CDA0C3D18A

Q37698199-99FB2648-CE0B-49BE-BB52-7B4229F48EAD

Q37698199-B3DE8936-5AED-409C-867E-76CC787E27AF

Q37698199-CA9901CC-B025-40EE-833A-6C7EAD0623ED

P2860

Q37698199-0DB12C75-4A3A-4B6C-8646-A8B92D30786B

Q37698199-24455CAD-A9EE-4BB9-BFF6-259C87A842C8

Q37698199-342D95FA-E3E7-413B-8D72-937453FE7763

Q37698199-3E86D8EE-5EF4-4FCB-85A9-5CC736CE3FF1

Q37698199-41BC5D13-F933-462E-B033-1C5EDCC793EB

Q37698199-48671789-F00E-499F-9F02-59766E8078AF

Q37698199-544D9471-4C26-4017-AD0D-12CC78B0220A

Q37698199-55EB8805-1C9D-493E-B892-10512DEBE875

Q37698199-5BCB341B-A05A-4578-96E5-77DC8DAC2336

Q37698199-6382FA46-D4A5-4E1B-BB68-D280DA271E71

P304

Q37698199-8D37F009-BD40-4D85-9405-7A96546A717F

P31

Q37698199-36C05713-9CC4-4525-8708-996C0CF3ABF7

P356

Q37698199-50CC72ED-7AF1-40CA-823A-226F06450B9D

P433

Q37698199-FF2A1FBD-9C80-4E33-9B4E-3706FBE7F670

P478

Q37698199-CB414FA5-195E-46D7-8407-7322A4FA6EAB

P50

Q37698199-40167027-0A35-41C5-BCE8-E9C2A77BC266

Q37698199-72DA2D2A-5EB8-4C95-99A7-7670FA61E992

P577

Q37698199-D2E8BDA3-DAB2-4F22-AD46-03D271AACF2F

P5875

Q37698199-8186B7BE-0E94-4D28-A69C-7B55A210CC1B

P698

Q37698199-4DBADE74-1134-4985-A3CC-B6982019DE7E

P932

Q37698199-EC4FD3D5-5A6F-4C8B-974D-AD5009AF6186

P356

THEONCOLOGIST.2013-0282

P1433

P1476

Eribulin monotherapy in patients aged 70 years and older with metastatic breast cancer.

@en

P2093

Chris Twelves

http://www.w3.org/2001/XMLSchema#string

Corina E Dutcus

http://www.w3.org/2001/XMLSchema#string

Hyman Muss

http://www.w3.org/2001/XMLSchema#string

Jantien Wanders

http://www.w3.org/2001/XMLSchema#string

Jay Yang

http://www.w3.org/2001/XMLSchema#string

Joyce O'Shaughnessy

http://www.w3.org/2001/XMLSchema#string

Linda T Vahdat

http://www.w3.org/2001/XMLSchema#string

Seth Seegobin

http://www.w3.org/2001/XMLSchema#string

P2860

Eribulin binds at microtubule ends to a single site on tubulin to suppress dynamic instability

Inhibition of centromere dynamics by eribulin (E7389) during mitotic metaphase

In vitro and in vivo anticancer activities of synthetic macrocyclic ketone analogues of halichondrin B

The primary antimitotic mechanism of action of the synthetic halichondrin E7389 is suppression of microtubule growth

Implementing a geriatric assessment in cooperative group clinical cancer trials: CALGB 360401

The treatment of early breast cancer in women over the age of 70

Paclitaxel efficacy and toxicity in older women with metastatic breast cancer: combined analysis of CALGB 9342 and 9840.

Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women

Non-standard management of breast cancer increases with age in the UK: a population based cohort of women > or =65 years.

Older female cancer patients: importance, causes, and consequences of undertreatment.

P304

318-327

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1634/THEONCOLOGIST.2013-0282

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-03-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261221346

http://www.w3.org/2001/XMLSchema#string

P698

24682463

http://www.w3.org/2001/XMLSchema#string

P932

3983814

http://www.w3.org/2001/XMLSchema#string